Respiri has teamed up with mTelehealth to provide customers with the Wheezo device for evaluation, testing and pilot programs, which are considered the first steps towards seeking reimbursement for the device mTelehealth placed a second order for additional Wheezo devices, representing revenues of around US$24,000 (around A$33,600) on top of the US$150,000 (A$210,000) order received […]
• mTelehealth to provide paying customers with devices for evaluation, testing and pilot programs, the first steps in seeking to secure reimbursement for wheezo®. • Targeted senior medical decision makers from over 600 of mTelehealth target customers will be provided with wheezo® devices to allow for internal review, testing and pilot programs. • The institutions […]
ASX ANNOUNCEMENT23 December 2021 Respiri enters its first 5 year Remote Patient Monitoring (RPM) Distribution/Marketing Agreement in the United States with mTelehealth, LLCHighlights:• Five-year, Non-Exclusive Distribution and Marketing Agreement signed with mTelehealth in the key USmarket• mTelehealth is a premier provider of RPM services based in Florida• First key distribution and marketing agreement signed in […]
The e-health company’s shares closed in the green today on news of a new partnership Published December 23, 4:39pm AEDT The Respiri Ltd (ASX: RSH) share price leapt 14% to 6.5 cents in early trading this morning. This came following the announcement of a distribution and marketing deal with a United States healthcare company. At the closing bell, Respiri shares had […]
Markets Reporter jessica.defreitas@themarketherald.com.au 23 December 2021 14:54 (AEDT) Respiri (RSH) signs a five-year non-exclusive distribution and marketing deal with US-based remote patient monitoring (RPM) and chronic care provider, mTelehealth mTelehealth will initially order US$150,000 (A$208,087) worth of wheezo devices and services but the deal is expected to generate US$1 million (A$1.4 million) in sales Respiri believes […]
September 28, 2021 – All those with Chronic Obstructive Pulmonary Disease (COPD) now can have access to the RESPIPLUS™ Living Well with COPD self-care resources through the Aetonix aTouchAway® digital platform. More than 2 million Canadians aged 35 and older are living with COPD, a debilitating condition that impacts every element of life for its […]
OTTAWA, ON, Sept. 14, 2021 /PRNewswire/ – The Trudell Medical Group (TMG) located in Ontario, Canada, owns a portfolio of Canadian and US companies, bringing innovative medical devices and services to healthcare professionals and patients in over 110 countries. Within the portfolio, Trudell Medical International (Canada) and Monaghan Medical (US) are renowned for their market-leading Aerochamber® and Aerobika® respiratory devices. ProResp is the leader in professional client-centered […]
Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing aid, Wheezo Wheezo monitors wheezing to manage and improve asthma With the green tick from the FDA, the company can now market and sell the technology in the United States On the market this afternoon, Respiri is in the grey […]
Results demonstrate mTelehealth’s Remote Patient Monitoring interventions for Cardiovascular Disease survivors were highly effective…